Literature DB >> 28197711

[Serous retinopathy: an important adverse event in tumor treatment].

I Lüdeke1, P Terheyden2, S Grisanti3, M Lüke3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28197711     DOI： 10.1007/s00347-017-0460-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  19 in total

1.  Improved overall survival in melanoma with combined dabrafenib and trametinib.

Authors:  Caroline Robert; Boguslawa Karaszewska; Jacob Schachter; Piotr Rutkowski; Andrzej Mackiewicz; Daniil Stroiakovski; Michael Lichinitser; Reinhard Dummer; Florent Grange; Laurent Mortier; Vanna Chiarion-Sileni; Kamil Drucis; Ivana Krajsova; Axel Hauschild; Paul Lorigan; Pascal Wolter; Georgina V Long; Keith Flaherty; Paul Nathan; Antoni Ribas; Anne-Marie Martin; Peng Sun; Wendy Crist; Jeff Legos; Stephen D Rubin; Shonda M Little; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Autofluorescence findings in acute exudative polymorphous vitelliform maculopathy.

Authors:  Veronika Vaclavik; Kenneth G-J Ooi; Alan C Bird; Anthony G Robson; Graham E Holder; Andrew R Webster
Journal:  Arch Ophthalmol       Date:  2007-02

3.  Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma.

Authors:  Lili Grunwald; Brad E Kligman; Carol L Shields
Journal:  Arch Ophthalmol       Date:  2011-08

4.  MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects.

Authors:  U Urner-Bloch; M Urner; N Jaberg-Bentele; A L Frauchiger; R Dummer; S M Goldinger
Journal:  Eur J Cancer       Date:  2016-08-03       Impact factor: 9.162

5.  Multimodal Imaging Features in Acute Exudative Paraneoplastic Polymorphous Vitelliform Maculopathy.

Authors:  Daniel Q Li; John Golding; Carl Glittenberg; Netan Choudhry
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-12-01       Impact factor: 1.300

6.  Transient MEK inhibitor-associated retinopathy in metastatic melanoma.

Authors:  U Urner-Bloch; M Urner; P Stieger; N Galliker; N Winterton; A Zubel; L Moutouh-de Parseval; R Dummer; S M Goldinger
Journal:  Ann Oncol       Date:  2014-05-26       Impact factor: 32.976

7.  Acute exudative polymorphous vitelliform maculopathy.

Authors:  J D Gass; E L Chuang; H Granek
Journal:  Trans Am Ophthalmol Soc       Date:  1988

8.  Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.

Authors:  Elon H C van Dijk; Carla M L van Herpen; Marina Marinkovic; John B A G Haanen; Drake Amundson; Gré P M Luyten; Martine J Jager; Ellen H W Kapiteijn; Jan E E Keunen; Grazyna Adamus; Camiel J F Boon
Journal:  Ophthalmology       Date:  2015-06-26       Impact factor: 12.079

Review 9.  Central serous chorioretinopathy.

Authors:  Maria Wang; Inger Christine Munch; Pascal W Hasler; Christian Prünte; Michael Larsen
Journal:  Acta Ophthalmol       Date:  2007-07-28       Impact factor: 3.761

10.  Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.

Authors:  Jia Yu; Chunhui Jiang; Gezhi Xu
Journal:  Am J Ophthalmol       Date:  2014-06-25       Impact factor: 5.258
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.